Our exclusive analysis we did for the Genesis conference (organized by our partner Onenucleus). Download the report >> Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
Year: 2014
UK Life Sciences Trend Analysis 2014
2013 closed with the total venture financing value raised by Biotech companies in the U.K. being decreased by 47% compared to its 2012 level (USD 283m in 2013 compared to USD 530m in 2012). The number of U.K. biotech products (therapeutics and diagnostics) in the first stage of the clinical pipeline (Phase I) was increased … Continue reading UK Life Sciences Trend Analysis 2014
Nordic Life Sciences Database launched
The new Nordic Life Sciences Database is a directory including more than 2,500 companies from northern Europe which are active in the Biotech, Medtech and Pharma area. Thanks to our Scandinavian partners, company profiles from Denmark, Sweden and Norway are currently available. Try out the Nordic Life Sciences Database now: www.nordic-lifesciences.com Looking for your next … Continue reading Nordic Life Sciences Database launched
Canadian Life Sciences Trend Analysis 2014
In 2013 the venture capital raised by Biotechnology companies in Canada almost doubled (93% increase) compared to the previous year’s figure, to reach a total of USD 139m. The majority of Biotech products in the industry belong to the area of oncology, followed by products developed for nervous system and for Infectious diseases indications. Distributors, … Continue reading Canadian Life Sciences Trend Analysis 2014
Danish Life Sciences Trend Analysis 2014
In 2013, the total venture financing value amassed by Danish Biotechnology companies was by 64% increased compared to the previous year’s figure (USD 82m in 2013 compared to USD 50m in 2012). This summer’s snapshot of the Danish biotech industry reveals that 1 in 10 biotech companies are publicly traded; a 4 percentage point increase … Continue reading Danish Life Sciences Trend Analysis 2014
Swedish Life Sciences Trend Analysis 2014
2013 saw the Swedish Biotech Industry raising a significantly smaller venture financing amount than in the year before (USD 27m compared to USD 127m in 2012). During the same period the number of companies achieving an IPO exit doubled. The number of biotech products in Phase I of development remained stable compared to last year, … Continue reading Swedish Life Sciences Trend Analysis 2014
New Dutch Life Science Database launched
Venture Valuation owned Biotechgate announces the new partnership with HollandBIO. Together with the existing partner Medical Delta a new life sciences directory for the Netherland has been launched. Click here to read the press release >> Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. … Continue reading New Dutch Life Science Database launched
French Life Sciences Trend Analysis 2014
The number of Biotech (Therapeutics and Diagnostics) companies founded in France in 2013 was double that of the previous year. At the same time, the 2013 total venture financing value was increased for a third consecutive year, reaching USD 197m; 30% higher than in 2012 (USD 151m). Click here to download French Life Sciences Trend … Continue reading French Life Sciences Trend Analysis 2014
German Life Sciences Trend Analysis 2014
In 2013, the total financing value raised by private, Biotech companies in Germany was reduced by 31% compared to last year’s figure (USD 210m from what was USD 305m in 2012). However, this summer’s snapshot of the German biotech industry, suggests that the therapeutics pipeline is revitalized, since the number of products in earlier stages … Continue reading German Life Sciences Trend Analysis 2014
Dutch Life Sciences Trend Analysis 2014
With a strong finish in the second half of 2013, the Dutch, private biotechnology companies closed the year having amassed a total of USD 158m in venture financing. The strongest therapeutic areas, as represented by the biotech product pipeline (Therapeutics and Diagnostics), are those of Oncology (53 products in development), Infectious Diseases (36 products) and … Continue reading Dutch Life Sciences Trend Analysis 2014